Homozygous deletions within human chromosome band 9p21 in melanoma.
PDF (1.2M)
+5 authors
Journal: 1992/December - Proceedings of the National Academy of Sciences of the United States of America
ISSN: 0027-8424
PUBMED: 1438246
Abstract:
Genetic studies have implicated the early involvement of a gene on chromosome arm 9p in the development of cutaneous melanoma. We have performed loss-of-heterozygosity studies to confirm these original findings and identify the most frequently rearranged or deleted region of 9p. Eight markers were analyzed, including (from 9pter to proximal 9q) D9S33, the beta-interferon (IFNB1) locus, the alpha-interferon (IFNA) gene cluster, D9S126, D9S3, D9S19, the glycoprotein 4 beta-galactosyltransferase (GGTB2) gene, and the argininosuccinate synthetase pseudogene 3 (ASSP3). Two or more of these loci were found to be hemizygously reduced in 12 of 14 (86%) informative metastatic melanoma tumor and cell line DNAs, and homozygous deletions of the marker D9S126 were observed in 2 of 20 (10%) melanoma cell lines. These findings have resulted in the identification of a small critical region of 2-3 megabases on 9p21 in which a putative melanoma tumor-suppressor gene appears likely to reside. Several 9p candidate genes, including IFNB1, the IFNA gene cluster, GGTB2, and the tyrosinase-related protein (TYRP) locus, have all been eliminated as potential targets because they are located outside of the homozygously deleted regions.
Open in
PUBMED | PMC | Google Scholar | Wikipedia
Relations:
Content
Citations
(53)
References
(42)
Diseases
(1)
Conditions
(1)
Chemicals
(8)
Organisms
(1)
Processes
(3)
Anatomy
(2)
Affiliates
(1)
Similar articles
Articles by the same authors
Discussion board
Proc Natl Acad Sci U S A 89(21): 10557-10561
PMID: 1438246

Homozygous deletions within human chromosome band 9p21 in melanoma.

Abstract

Genetic studies have implicated the early involvement of a gene on chromosome arm 9p in the development of cutaneous melanoma. We have performed loss-of-heterozygosity studies to confirm these original findings and identify the most frequently rearranged or deleted region of 9p. Eight markers were analyzed, including (from 9pter to proximal 9q) D9S33, the beta-interferon (IFNB1) locus, the alpha-interferon (IFNA) gene cluster, D9S126, D9S3, D9S19, the glycoprotein 4 beta-galactosyltransferase (GGTB2) gene, and the argininosuccinate synthetase pseudogene 3 (ASSP3). Two or more of these loci were found to be hemizygously reduced in 12 of 14 (86%) informative metastatic melanoma tumor and cell line DNAs, and homozygous deletions of the marker D9S126 were observed in 2 of 20 (10%) melanoma cell lines. These findings have resulted in the identification of a small critical region of 2-3 megabases on 9p21 in which a putative melanoma tumor-suppressor gene appears likely to reside. Several 9p candidate genes, including IFNB1, the IFNA gene cluster, GGTB2, and the tyrosinase-related protein (TYRP) locus, have all been eliminated as potential targets because they are located outside of the homozygously deleted regions.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
icon of scanned page 10557
10557
icon of scanned page 10558
10558
icon of scanned page 10559
10559
icon of scanned page 10560
10560
icon of scanned page 10561
10561

Images in this article

Image
Image
on p.10559
Image
Image
on p.10559
Image
Image
on p.10560
Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Fountain JW, Bale SJ, Housman DE, Dracopoli NC. Genetics of melanoma. Cancer Surv. 1990;9(4):645–671. [PubMed] [Google Scholar]
  • Dracopoli NC, Alhadeff B, Houghton AN, Old LJ. Loss of heterozygosity at autosomal and X-linked loci during tumor progression in a patient with melanoma. Cancer Res. 1987 Aug 1;47(15):3995–4000. [PubMed] [Google Scholar]
  • Cowan JM, Halaban R, Francke U. Cytogenetic analysis of melanocytes from premalignant nevi and melanomas. J Natl Cancer Inst. 1988 Sep 21;80(14):1159–1164. [PubMed] [Google Scholar]
  • Pedersen MI, Wang N. Chromosomal evolution in the progression and metastasis of human malignant melanoma. A multiple lesion study. Cancer Genet Cytogenet. 1989 Sep;41(2):185–201. [PubMed] [Google Scholar]
  • Kacker RK, Giovanella BC, Pathak S. Consistent karyotypic abnormalities in human malignant melanomas. Anticancer Res. 1990 Jul-Aug;10(4):859–871. [PubMed] [Google Scholar]
  • Smith M, Simpson NE. Report of the committee on the genetic constitution of chromosomes 9 and 10. Cytogenet Cell Genet. 1989;51(1-4):202–225. [PubMed] [Google Scholar]
  • Kirkwood JM, Ernstoff MS, Davis CA, Reiss M, Ferraresi R, Rudnick SA. Comparison of intramuscular and intravenous recombinant alpha-2 interferon in melanoma and other cancers. Ann Intern Med. 1985 Jul;103(1):32–36. [PubMed] [Google Scholar]
  • Creagan ET, Ahmann DL, Frytak S, Long HJ, Itri LM. Recombinant leukocyte A interferon (rIFN-alpha A) in the treatment of disseminated malignant melanoma. Analysis of complete and long-term responding patients. Cancer. 1986 Dec 15;58(12):2576–2578. [PubMed] [Google Scholar]
  • Yaar M, Palleroni AV, Gilchrest BA. Normal human epidermis contains an interferon-like protein. J Cell Biol. 1986 Oct;103(4):1349–1354.[PMC free article] [PubMed] [Google Scholar]
  • Roseman S. The synthesis of complex carbohydrates by multiglycosyltransferase systems and their potential function in intercellular adhesion. Chem Phys Lipids. 1970 Oct;5(1):270–297. [PubMed] [Google Scholar]
  • LaMont JT, Gammon MT, Isselbacher KJ. Cell-surface glycosyltransferases in cultured fibroblasts: increased activity and release during serum stimulation of growth. Proc Natl Acad Sci U S A. 1977 Mar;74(3):1086–1090.[PMC free article] [PubMed] [Google Scholar]
  • Vijayasaradhi S, Bouchard B, Houghton AN. The melanoma antigen gp75 is the human homologue of the mouse b (brown) locus gene product. J Exp Med. 1990 Apr 1;171(4):1375–1380.[PMC free article] [PubMed] [Google Scholar]
  • Cohen T, Muller RM, Tomita Y, Shibahara S. Nucleotide sequence of the cDNA encoding human tyrosinase-related protein. Nucleic Acids Res. 1990 May 11;18(9):2807–2808.[PMC free article] [PubMed] [Google Scholar]
  • Jackson IJ. A cDNA encoding tyrosinase-related protein maps to the brown locus in mouse. Proc Natl Acad Sci U S A. 1988 Jun;85(12):4392–4396.[PMC free article] [PubMed] [Google Scholar]
  • Mattes MJ, Thomson TM, Old LJ, Lloyd KO. A pigmentation-associated, differentiation antigen of human melanoma defined by a precipitating antibody in human serum. Int J Cancer. 1983 Dec 15;32(6):717–721. [PubMed] [Google Scholar]
  • Tai T, Eisinger M, Ogata S, Lloyd KO. Glycoproteins as differentiation markers in human malignant melanoma and melanocytes. Cancer Res. 1983 Jun;43(6):2773–2779. [PubMed] [Google Scholar]
  • Thomson TM, Real FX, Murakami S, Cordon-Cardo C, Old LJ, Houghton AN. Differentiation antigens of melanocytes and melanoma: analysis of melanosome and cell surface markers of human pigmented cells with monoclonal antibodies. J Invest Dermatol. 1988 Apr;90(4):459–466. [PubMed] [Google Scholar]
  • Houghton AN, Real FX, Davis LJ, Cordon-Cardo C, Old LJ. Phenotypic heterogeneity of melanoma. Relation to the differentiation program of melanoma cells. J Exp Med. 1987 Mar 1;165(3):812–829.[PMC free article] [PubMed] [Google Scholar]
  • Abbott C, Jackson IJ, Carritt B, Povey S. The human homolog of the mouse brown gene maps to the short arm of chromosome 9 and extends the known region of homology with mouse chromosome 4. Genomics. 1991 Oct;11(2):471–473. [PubMed] [Google Scholar]
  • Murty VV, Bouchard B, Mathew S, Vijayasaradhi S, Houghton AN. Assignment of the human TYRP (brown) locus to chromosome region 9p23 by nonradioactive in situ hybridization. Genomics. 1992 May;13(1):227–229. [PubMed] [Google Scholar]
  • Fountain JW, Karayiorgou M, Taruscio D, Graw SL, Buckler AJ, Ward DC, Dracopoli NC, Housman DE. Genetic and physical map of the interferon region on chromosome 9p. Genomics. 1992 Sep;14(1):105–112. [PubMed] [Google Scholar]
  • Dracopoli NC, Houghton AN, Old LJ. Loss of polymorphic restriction fragments in malignant melanoma: implications for tumor heterogeneity. Proc Natl Acad Sci U S A. 1985 Mar;82(5):1470–1474.[PMC free article] [PubMed] [Google Scholar]
  • Warburton D, Gersen S, Yu MT, Jackson C, Handelin B, Housman D. Monochromosomal rodent-human hybrids from microcell fusion of human lymphoblastoid cells containing an inserted dominant selectable marker. Genomics. 1990 Feb;6(2):358–366. [PubMed] [Google Scholar]
  • Jackson CL, Britt DE, Graw SL, Potts A, Santoro K, Buckler AJ, Housman DE, Mark HF. Construction and characterization of radiation hybrids for chromosome 9, and their use in mapping cosmid probes on the chromosome. Somat Cell Mol Genet. 1992 May;18(3):285–301. [PubMed] [Google Scholar]
  • Fountain JW, Wallace MR, Brereton AM, O'Connell P, White RL, Rich DC, Ledbetter DH, Leach RJ, Fournier RE, Menon AG, et al. Physical mapping of the von Recklinghausen neurofibromatosis region on chromosome 17. Am J Hum Genet. 1989 Jan;44(1):58–67.[PMC free article] [PubMed] [Google Scholar]
  • Pouncey L, Easton J, Heath LS, Grenet J, Kidd VJ. Beta 1-4-galactosyltransferase gene expression is regulated during entry into the cell cycle and during the cell cycle. Somat Cell Mol Genet. 1991 Sep;17(5):435–443. [PubMed] [Google Scholar]
  • Orita M, Murakami Y, Ishihara K, Sekiya T. Loss of heterozygosity at polymorphic chromosomal loci in patients with malignant melanoma. J Invest Dermatol. 1989 May;92(5 Suppl):280S–283S. [PubMed] [Google Scholar]
  • Dracopoli NC, Harnett P, Bale SJ, Stanger BZ, Tucker MA, Housman DE, Kefford RF. Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression. Proc Natl Acad Sci U S A. 1989 Jun;86(12):4614–4618.[PMC free article] [PubMed] [Google Scholar]
  • Millikin D, Meese E, Vogelstein B, Witkowski C, Trent J. Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma. Cancer Res. 1991 Oct 15;51(20):5449–5453. [PubMed] [Google Scholar]
  • Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature. 1986 Oct 16;323(6089):643–646. [PubMed] [Google Scholar]
  • Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH, et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell. 1990 Feb 9;60(3):509–520. [PubMed] [Google Scholar]
  • Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, Hamilton SR, Preisinger AC, Thomas G, Kinzler KW, et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science. 1990 Jan 5;247(4938):49–56. [PubMed] [Google Scholar]
  • Jonasson J, Povey S, Harris H. The analysis of malignancy by cell fusion. VII. Cytogenetic analysis of hybrids between malignant and diploid cells and of tumours derived from them. J Cell Sci. 1977 Apr;24:217–254. [PubMed] [Google Scholar]
  • Bigner SH, Mark J, Bullard DE, Mahaley MS, Jr, Bigner DD. Chromosomal evolution in malignant human gliomas starts with specific and usually numerical deviations. Cancer Genet Cytogenet. 1986 Jun;22(2):121–135. [PubMed] [Google Scholar]
  • Diaz MO, Ziemin S, Le Beau MM, Pitha P, Smith SD, Chilcote RR, Rowley JD. Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines. Proc Natl Acad Sci U S A. 1988 Jul;85(14):5259–5263.[PMC free article] [PubMed] [Google Scholar]
  • Diaz MO, Rubin CM, Harden A, Ziemin S, Larson RA, Le Beau MM, Rowley JD. Deletions of interferon genes in acute lymphoblastic leukemia. N Engl J Med. 1990 Jan 11;322(2):77–82. [PubMed] [Google Scholar]
  • Lukeis R, Irving L, Garson M, Hasthorpe S. Cytogenetics of non-small cell lung cancer: analysis of consistent non-random abnormalities. Genes Chromosomes Cancer. 1990 Jul;2(2):116–124. [PubMed] [Google Scholar]
  • Miyakoshi J, Dobler KD, Allalunis-Turner J, McKean JD, Petruk K, Allen PB, Aronyk KN, Weir B, Huyser-Wierenga D, Fulton D, et al. Absence of IFNA and IFNB genes from human malignant glioma cell lines and lack of correlation with cellular sensitivity to interferons. Cancer Res. 1990 Jan 15;50(2):278–283. [PubMed] [Google Scholar]
  • Einhorn S, Grandér D, Björk O, Bröndum-Nielsen K, Söderhäll S. Deletion of alpha-, beta-, and omega-interferon genes in malignant cells from children with acute lymphocytic leukemia. Cancer Res. 1990 Dec 15;50(24):7781–7785. [PubMed] [Google Scholar]
  • James CD, He J, Carlbom E, Nordenskjold M, Cavenee WK, Collins VP. Chromosome 9 deletion mapping reveals interferon alpha and interferon beta-1 gene deletions in human glial tumors. Cancer Res. 1991 Mar 15;51(6):1684–1688. [PubMed] [Google Scholar]
  • Middleton PG, Prince RA, Williamson IK, Taylor PR, Reid MM, Jackson GH, Katz F, Chessells JM, Proctor SJ. Alpha interferon gene deletions in adults, children and infants with acute lymphoblastic leukemia. Leukemia. 1991 Aug;5(8):680–682. [PubMed] [Google Scholar]
  • Olopade OI, Jenkins RB, Ransom DT, Malik K, Pomykala H, Nobori T, Cowan JM, Rowley JD, Diaz MO. Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas. Cancer Res. 1992 May 1;52(9):2523–2529. [PubMed] [Google Scholar]
, et al.
Center for Cancer Research, Massachusetts Institute of Technology, Cambridge 02139.
Center for Cancer Research, Massachusetts Institute of Technology, Cambridge 02139.
Copyright notice
Abstract
Genetic studies have implicated the early involvement of a gene on chromosome arm 9p in the development of cutaneous melanoma. We have performed loss-of-heterozygosity studies to confirm these original findings and identify the most frequently rearranged or deleted region of 9p. Eight markers were analyzed, including (from 9pter to proximal 9q) D9S33, the beta-interferon (IFNB1) locus, the alpha-interferon (IFNA) gene cluster, D9S126, D9S3, D9S19, the glycoprotein 4 beta-galactosyltransferase (GGTB2) gene, and the argininosuccinate synthetase pseudogene 3 (ASSP3). Two or more of these loci were found to be hemizygously reduced in 12 of 14 (86%) informative metastatic melanoma tumor and cell line DNAs, and homozygous deletions of the marker D9S126 were observed in 2 of 20 (10%) melanoma cell lines. These findings have resulted in the identification of a small critical region of 2-3 megabases on 9p21 in which a putative melanoma tumor-suppressor gene appears likely to reside. Several 9p candidate genes, including IFNB1, the IFNA gene cluster, GGTB2, and the tyrosinase-related protein (TYRP) locus, have all been eliminated as potential targets because they are located outside of the homozygously deleted regions.
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.